drugset / Trial / NCT06863636

Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation

NCT06863636

Phase 3 Recruiting 231 enrolled Laboratorios Silanes S.A. de C.V.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase III, longitudinal, multicenter, randomized, double-blind clinical trial designed to evaluate the efficacy and safety of a fixed-dose combination of celecoxib and acetaminophen compared to celecoxib monotherapy for the treatment of pain associated with acute exacerbations of osteoarthritis.

Timeline

Start
2024-09-09
Primary completion
2025-10-30
Completion
2025-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 200 mg Oral
Subject Acetaminophen Small molecule 500 mg Oral
Subject Celecoxib Other / unclassified 200 mg Oral